Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals

Polyethylene glycol (PEG) is a biocompatible polymer that is often attached to therapeutic molecules to improve bioavailability and therapeutic efficacy. Although antibodies with specificity for PEG may compromise the safety and effectiveness of PEGylated medicines, the prevalence of pre-existing an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Analytical chemistry (Washington) 2016-11, Vol.88 (21), p.10661-10666
Hauptverfasser: Chen, Bing-Mae, Su, Yu-Cheng, Chang, Chia-Jung, Burnouf, Pierre-Alain, Chuang, Kuo-Hsiang, Chen, Chien-Hsiun, Cheng, Tian-Lu, Chen, Yuan-Tsong, Wu, Jer-Yuarn, Roffler, Steve R
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10666
container_issue 21
container_start_page 10661
container_title Analytical chemistry (Washington)
container_volume 88
creator Chen, Bing-Mae
Su, Yu-Cheng
Chang, Chia-Jung
Burnouf, Pierre-Alain
Chuang, Kuo-Hsiang
Chen, Chien-Hsiun
Cheng, Tian-Lu
Chen, Yuan-Tsong
Wu, Jer-Yuarn
Roffler, Steve R
description Polyethylene glycol (PEG) is a biocompatible polymer that is often attached to therapeutic molecules to improve bioavailability and therapeutic efficacy. Although antibodies with specificity for PEG may compromise the safety and effectiveness of PEGylated medicines, the prevalence of pre-existing anti-PEG antibodies in healthy individuals is unclear. Chimeric human anti-PEG antibody standards were created to accurately measure anti-PEG IgM and IgG antibodies by direct ELISA with confirmation by a competition assay in the plasma of 1504 healthy Han Chinese donors residing in Taiwan. Anti-PEG antibodies were detected in 44.3% of healthy donors with a high prevalence of both anti-PEG IgM (27.1%) and anti-PEG IgG (25.7%). Anti-PEG IgM and IgG antibodies were significantly more common in females as compared to males (32.0% vs 22.2% for IgM, p < 0.0001 and 28.3% vs 23.0% for IgG, p = 0.018). The prevalence of anti-PEG IgG antibodies was higher in younger (up to 60% for 20 year olds) as opposed to older (20% for >50 years) male and female donors. Anti-PEG IgG concentrations were negatively associated with donor age in both females (p = 0.0073) and males (p = 0.026). Both anti-PEG IgM and IgG strongly bound PEGylated medicines. The described assay can assist in the elucidation of the impact of anti-PEG antibodies on the safety and therapeutic efficacy of PEGylated medicines.
doi_str_mv 10.1021/acs.analchem.6b03109
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1864583487</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4240624351</sourcerecordid><originalsourceid>FETCH-LOGICAL-a545t-e6718466fbb5a62f201fa01dd3eb8e03ef2db8c654ae64ecc1d1f84bb02b41c43</originalsourceid><addsrcrecordid>eNqNkUtr3DAUhUVpaaZp_0Epgm6y8fTqYVlehjCdDCQ0i3Zt9LieKMhyatkh8-_ryUwa6CJ0deDynSPQR8hnBksGnH0zLi9NMtHdYrdUFgSD-g1ZsJJDobTmb8kCAETBK4AT8iHnOwDGgKn35IRXFVeiqhcEr9HkacAO00j7lt4MWKweQx5D2tLNdk1N8nNe0_M0Btv7gJmarQkpj_Smjzscb3cRE9J13Lk-0pDoJZo4X-km-fAQ_GRi_kjetXPgp2Oekl_fVz8vLourH-vNxflVYUpZjgWqimmpVGttaRRvObDWAPNeoNUIAlvurXaqlAaVROeYZ62W1gK3kjkpTsnZYfd-6H9PmMemC9lhjCZhP-WGaSVLLaSu_gMVsq6FUHv06z_oXT8N89c_UarUUItypuSBckOf84Btcz-Ezgy7hkGzN9bMxppnY83R2Fz7chyfbIf-b-lZ0QzAAdjXXx5-bfMPiFOlJw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1836580935</pqid></control><display><type>article</type><title>Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals</title><source>ACS Publications</source><source>MEDLINE</source><creator>Chen, Bing-Mae ; Su, Yu-Cheng ; Chang, Chia-Jung ; Burnouf, Pierre-Alain ; Chuang, Kuo-Hsiang ; Chen, Chien-Hsiun ; Cheng, Tian-Lu ; Chen, Yuan-Tsong ; Wu, Jer-Yuarn ; Roffler, Steve R</creator><creatorcontrib>Chen, Bing-Mae ; Su, Yu-Cheng ; Chang, Chia-Jung ; Burnouf, Pierre-Alain ; Chuang, Kuo-Hsiang ; Chen, Chien-Hsiun ; Cheng, Tian-Lu ; Chen, Yuan-Tsong ; Wu, Jer-Yuarn ; Roffler, Steve R</creatorcontrib><description>Polyethylene glycol (PEG) is a biocompatible polymer that is often attached to therapeutic molecules to improve bioavailability and therapeutic efficacy. Although antibodies with specificity for PEG may compromise the safety and effectiveness of PEGylated medicines, the prevalence of pre-existing anti-PEG antibodies in healthy individuals is unclear. Chimeric human anti-PEG antibody standards were created to accurately measure anti-PEG IgM and IgG antibodies by direct ELISA with confirmation by a competition assay in the plasma of 1504 healthy Han Chinese donors residing in Taiwan. Anti-PEG antibodies were detected in 44.3% of healthy donors with a high prevalence of both anti-PEG IgM (27.1%) and anti-PEG IgG (25.7%). Anti-PEG IgM and IgG antibodies were significantly more common in females as compared to males (32.0% vs 22.2% for IgM, p &lt; 0.0001 and 28.3% vs 23.0% for IgG, p = 0.018). The prevalence of anti-PEG IgG antibodies was higher in younger (up to 60% for 20 year olds) as opposed to older (20% for &gt;50 years) male and female donors. Anti-PEG IgG concentrations were negatively associated with donor age in both females (p = 0.0073) and males (p = 0.026). Both anti-PEG IgM and IgG strongly bound PEGylated medicines. The described assay can assist in the elucidation of the impact of anti-PEG antibodies on the safety and therapeutic efficacy of PEGylated medicines.</description><identifier>ISSN: 0003-2700</identifier><identifier>EISSN: 1520-6882</identifier><identifier>DOI: 10.1021/acs.analchem.6b03109</identifier><identifier>PMID: 27726379</identifier><identifier>CODEN: ANCHAM</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Animals ; Antibodies ; Asian Continental Ancestry Group ; Biocompatibility ; Biopolymers ; Doxorubicin - analogs &amp; derivatives ; Doxorubicin - immunology ; Effectiveness ; Enzyme-Linked Immunosorbent Assay - methods ; Female ; Females ; Humans ; IgG antibody ; Immunoassay ; Immunoglobulin G - blood ; Immunoglobulin G - immunology ; Immunoglobulin M - blood ; Immunoglobulin M - immunology ; Immunoglobulins ; Interferon-alpha - immunology ; Male ; Males ; Measurement ; Medicine ; Mice ; Middle Aged ; Polyethylene glycol ; Polyethylene Glycols - metabolism ; Recombinant Fusion Proteins - immunology ; Recombinant Proteins - immunology ; Safety ; Young Adult</subject><ispartof>Analytical chemistry (Washington), 2016-11, Vol.88 (21), p.10661-10666</ispartof><rights>Copyright © 2016 American Chemical Society</rights><rights>Copyright American Chemical Society Nov 1, 2016</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a545t-e6718466fbb5a62f201fa01dd3eb8e03ef2db8c654ae64ecc1d1f84bb02b41c43</citedby><cites>FETCH-LOGICAL-a545t-e6718466fbb5a62f201fa01dd3eb8e03ef2db8c654ae64ecc1d1f84bb02b41c43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.analchem.6b03109$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.analchem.6b03109$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27726379$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Bing-Mae</creatorcontrib><creatorcontrib>Su, Yu-Cheng</creatorcontrib><creatorcontrib>Chang, Chia-Jung</creatorcontrib><creatorcontrib>Burnouf, Pierre-Alain</creatorcontrib><creatorcontrib>Chuang, Kuo-Hsiang</creatorcontrib><creatorcontrib>Chen, Chien-Hsiun</creatorcontrib><creatorcontrib>Cheng, Tian-Lu</creatorcontrib><creatorcontrib>Chen, Yuan-Tsong</creatorcontrib><creatorcontrib>Wu, Jer-Yuarn</creatorcontrib><creatorcontrib>Roffler, Steve R</creatorcontrib><title>Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals</title><title>Analytical chemistry (Washington)</title><addtitle>Anal. Chem</addtitle><description>Polyethylene glycol (PEG) is a biocompatible polymer that is often attached to therapeutic molecules to improve bioavailability and therapeutic efficacy. Although antibodies with specificity for PEG may compromise the safety and effectiveness of PEGylated medicines, the prevalence of pre-existing anti-PEG antibodies in healthy individuals is unclear. Chimeric human anti-PEG antibody standards were created to accurately measure anti-PEG IgM and IgG antibodies by direct ELISA with confirmation by a competition assay in the plasma of 1504 healthy Han Chinese donors residing in Taiwan. Anti-PEG antibodies were detected in 44.3% of healthy donors with a high prevalence of both anti-PEG IgM (27.1%) and anti-PEG IgG (25.7%). Anti-PEG IgM and IgG antibodies were significantly more common in females as compared to males (32.0% vs 22.2% for IgM, p &lt; 0.0001 and 28.3% vs 23.0% for IgG, p = 0.018). The prevalence of anti-PEG IgG antibodies was higher in younger (up to 60% for 20 year olds) as opposed to older (20% for &gt;50 years) male and female donors. Anti-PEG IgG concentrations were negatively associated with donor age in both females (p = 0.0073) and males (p = 0.026). Both anti-PEG IgM and IgG strongly bound PEGylated medicines. The described assay can assist in the elucidation of the impact of anti-PEG antibodies on the safety and therapeutic efficacy of PEGylated medicines.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Animals</subject><subject>Antibodies</subject><subject>Asian Continental Ancestry Group</subject><subject>Biocompatibility</subject><subject>Biopolymers</subject><subject>Doxorubicin - analogs &amp; derivatives</subject><subject>Doxorubicin - immunology</subject><subject>Effectiveness</subject><subject>Enzyme-Linked Immunosorbent Assay - methods</subject><subject>Female</subject><subject>Females</subject><subject>Humans</subject><subject>IgG antibody</subject><subject>Immunoassay</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin G - immunology</subject><subject>Immunoglobulin M - blood</subject><subject>Immunoglobulin M - immunology</subject><subject>Immunoglobulins</subject><subject>Interferon-alpha - immunology</subject><subject>Male</subject><subject>Males</subject><subject>Measurement</subject><subject>Medicine</subject><subject>Mice</subject><subject>Middle Aged</subject><subject>Polyethylene glycol</subject><subject>Polyethylene Glycols - metabolism</subject><subject>Recombinant Fusion Proteins - immunology</subject><subject>Recombinant Proteins - immunology</subject><subject>Safety</subject><subject>Young Adult</subject><issn>0003-2700</issn><issn>1520-6882</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkUtr3DAUhUVpaaZp_0Epgm6y8fTqYVlehjCdDCQ0i3Zt9LieKMhyatkh8-_ryUwa6CJ0deDynSPQR8hnBksGnH0zLi9NMtHdYrdUFgSD-g1ZsJJDobTmb8kCAETBK4AT8iHnOwDGgKn35IRXFVeiqhcEr9HkacAO00j7lt4MWKweQx5D2tLNdk1N8nNe0_M0Btv7gJmarQkpj_Smjzscb3cRE9J13Lk-0pDoJZo4X-km-fAQ_GRi_kjetXPgp2Oekl_fVz8vLourH-vNxflVYUpZjgWqimmpVGttaRRvObDWAPNeoNUIAlvurXaqlAaVROeYZ62W1gK3kjkpTsnZYfd-6H9PmMemC9lhjCZhP-WGaSVLLaSu_gMVsq6FUHv06z_oXT8N89c_UarUUItypuSBckOf84Btcz-Ezgy7hkGzN9bMxppnY83R2Fz7chyfbIf-b-lZ0QzAAdjXXx5-bfMPiFOlJw</recordid><startdate>20161101</startdate><enddate>20161101</enddate><creator>Chen, Bing-Mae</creator><creator>Su, Yu-Cheng</creator><creator>Chang, Chia-Jung</creator><creator>Burnouf, Pierre-Alain</creator><creator>Chuang, Kuo-Hsiang</creator><creator>Chen, Chien-Hsiun</creator><creator>Cheng, Tian-Lu</creator><creator>Chen, Yuan-Tsong</creator><creator>Wu, Jer-Yuarn</creator><creator>Roffler, Steve R</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QF</scope><scope>7QO</scope><scope>7QQ</scope><scope>7SC</scope><scope>7SE</scope><scope>7SP</scope><scope>7SR</scope><scope>7TA</scope><scope>7TB</scope><scope>7TM</scope><scope>7U5</scope><scope>7U7</scope><scope>7U9</scope><scope>8BQ</scope><scope>8FD</scope><scope>C1K</scope><scope>F28</scope><scope>FR3</scope><scope>H8D</scope><scope>H8G</scope><scope>H94</scope><scope>JG9</scope><scope>JQ2</scope><scope>KR7</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20161101</creationdate><title>Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals</title><author>Chen, Bing-Mae ; Su, Yu-Cheng ; Chang, Chia-Jung ; Burnouf, Pierre-Alain ; Chuang, Kuo-Hsiang ; Chen, Chien-Hsiun ; Cheng, Tian-Lu ; Chen, Yuan-Tsong ; Wu, Jer-Yuarn ; Roffler, Steve R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a545t-e6718466fbb5a62f201fa01dd3eb8e03ef2db8c654ae64ecc1d1f84bb02b41c43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Animals</topic><topic>Antibodies</topic><topic>Asian Continental Ancestry Group</topic><topic>Biocompatibility</topic><topic>Biopolymers</topic><topic>Doxorubicin - analogs &amp; derivatives</topic><topic>Doxorubicin - immunology</topic><topic>Effectiveness</topic><topic>Enzyme-Linked Immunosorbent Assay - methods</topic><topic>Female</topic><topic>Females</topic><topic>Humans</topic><topic>IgG antibody</topic><topic>Immunoassay</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin G - immunology</topic><topic>Immunoglobulin M - blood</topic><topic>Immunoglobulin M - immunology</topic><topic>Immunoglobulins</topic><topic>Interferon-alpha - immunology</topic><topic>Male</topic><topic>Males</topic><topic>Measurement</topic><topic>Medicine</topic><topic>Mice</topic><topic>Middle Aged</topic><topic>Polyethylene glycol</topic><topic>Polyethylene Glycols - metabolism</topic><topic>Recombinant Fusion Proteins - immunology</topic><topic>Recombinant Proteins - immunology</topic><topic>Safety</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Bing-Mae</creatorcontrib><creatorcontrib>Su, Yu-Cheng</creatorcontrib><creatorcontrib>Chang, Chia-Jung</creatorcontrib><creatorcontrib>Burnouf, Pierre-Alain</creatorcontrib><creatorcontrib>Chuang, Kuo-Hsiang</creatorcontrib><creatorcontrib>Chen, Chien-Hsiun</creatorcontrib><creatorcontrib>Cheng, Tian-Lu</creatorcontrib><creatorcontrib>Chen, Yuan-Tsong</creatorcontrib><creatorcontrib>Wu, Jer-Yuarn</creatorcontrib><creatorcontrib>Roffler, Steve R</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Aluminium Industry Abstracts</collection><collection>Biotechnology Research Abstracts</collection><collection>Ceramic Abstracts</collection><collection>Computer and Information Systems Abstracts</collection><collection>Corrosion Abstracts</collection><collection>Electronics &amp; Communications Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Materials Business File</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ANTE: Abstracts in New Technology &amp; Engineering</collection><collection>Engineering Research Database</collection><collection>Aerospace Database</collection><collection>Copper Technical Reference Library</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Civil Engineering Abstracts</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Analytical chemistry (Washington)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Bing-Mae</au><au>Su, Yu-Cheng</au><au>Chang, Chia-Jung</au><au>Burnouf, Pierre-Alain</au><au>Chuang, Kuo-Hsiang</au><au>Chen, Chien-Hsiun</au><au>Cheng, Tian-Lu</au><au>Chen, Yuan-Tsong</au><au>Wu, Jer-Yuarn</au><au>Roffler, Steve R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals</atitle><jtitle>Analytical chemistry (Washington)</jtitle><addtitle>Anal. Chem</addtitle><date>2016-11-01</date><risdate>2016</risdate><volume>88</volume><issue>21</issue><spage>10661</spage><epage>10666</epage><pages>10661-10666</pages><issn>0003-2700</issn><eissn>1520-6882</eissn><coden>ANCHAM</coden><abstract>Polyethylene glycol (PEG) is a biocompatible polymer that is often attached to therapeutic molecules to improve bioavailability and therapeutic efficacy. Although antibodies with specificity for PEG may compromise the safety and effectiveness of PEGylated medicines, the prevalence of pre-existing anti-PEG antibodies in healthy individuals is unclear. Chimeric human anti-PEG antibody standards were created to accurately measure anti-PEG IgM and IgG antibodies by direct ELISA with confirmation by a competition assay in the plasma of 1504 healthy Han Chinese donors residing in Taiwan. Anti-PEG antibodies were detected in 44.3% of healthy donors with a high prevalence of both anti-PEG IgM (27.1%) and anti-PEG IgG (25.7%). Anti-PEG IgM and IgG antibodies were significantly more common in females as compared to males (32.0% vs 22.2% for IgM, p &lt; 0.0001 and 28.3% vs 23.0% for IgG, p = 0.018). The prevalence of anti-PEG IgG antibodies was higher in younger (up to 60% for 20 year olds) as opposed to older (20% for &gt;50 years) male and female donors. Anti-PEG IgG concentrations were negatively associated with donor age in both females (p = 0.0073) and males (p = 0.026). Both anti-PEG IgM and IgG strongly bound PEGylated medicines. The described assay can assist in the elucidation of the impact of anti-PEG antibodies on the safety and therapeutic efficacy of PEGylated medicines.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>27726379</pmid><doi>10.1021/acs.analchem.6b03109</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-2700
ispartof Analytical chemistry (Washington), 2016-11, Vol.88 (21), p.10661-10666
issn 0003-2700
1520-6882
language eng
recordid cdi_proquest_miscellaneous_1864583487
source ACS Publications; MEDLINE
subjects Adult
Aged
Aged, 80 and over
Animals
Antibodies
Asian Continental Ancestry Group
Biocompatibility
Biopolymers
Doxorubicin - analogs & derivatives
Doxorubicin - immunology
Effectiveness
Enzyme-Linked Immunosorbent Assay - methods
Female
Females
Humans
IgG antibody
Immunoassay
Immunoglobulin G - blood
Immunoglobulin G - immunology
Immunoglobulin M - blood
Immunoglobulin M - immunology
Immunoglobulins
Interferon-alpha - immunology
Male
Males
Measurement
Medicine
Mice
Middle Aged
Polyethylene glycol
Polyethylene Glycols - metabolism
Recombinant Fusion Proteins - immunology
Recombinant Proteins - immunology
Safety
Young Adult
title Measurement of Pre-Existing IgG and IgM Antibodies against Polyethylene Glycol in Healthy Individuals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T14%3A42%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Measurement%20of%20Pre-Existing%20IgG%20and%20IgM%20Antibodies%20against%20Polyethylene%20Glycol%20in%20Healthy%20Individuals&rft.jtitle=Analytical%20chemistry%20(Washington)&rft.au=Chen,%20Bing-Mae&rft.date=2016-11-01&rft.volume=88&rft.issue=21&rft.spage=10661&rft.epage=10666&rft.pages=10661-10666&rft.issn=0003-2700&rft.eissn=1520-6882&rft.coden=ANCHAM&rft_id=info:doi/10.1021/acs.analchem.6b03109&rft_dat=%3Cproquest_cross%3E4240624351%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1836580935&rft_id=info:pmid/27726379&rfr_iscdi=true